Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use. - Proudman,SM.; Keen,HI.; Stamp,LK. (Semin Arthritis Rheum, 2007)